Yasmin Elsayed1, John Refaat1, Usama Ramadan Abdelmohsen1,2, Eman Maher Othman3,4, Helga Stopper4, Mostafa Ahmed Fouad1. 1. Department of Pharmacognosy, Faculty of Pharmacy, Minia University, Minia, Egypt. 2. Department of Botany II, Julius-von-Sachs Institute for Biological Sciences, University of Würzburg, Würzburg, Germany. 3. Department of Analytical Chemistry, Faculty of Pharmacy, Minia University, Minia, Egypt. 4. Department of Toxicology, University of Würzburg, Würzburg, Germany.
Abstract
INTRODUCTION: Marine sponge-associated actinomycetes are potent sources of bioactive natural products of pharmaceutical significance. They also contributed to the discovery of several clinically relevant antimicrobials. OBJECTIVE: To apply the non-targeted metabolomics approach in chemical profiling of the sponge-derived bacterium Rhodococcus sp. UA13, formerly recovered from the Red Sea sponge Callyspongia aff. Implexa, along with testing for the anti-infective potential of its different fractions. METHODOLOGY: Metabolomic analysis of the crude extract was carried out using liquid chromatography with high resolution electrospray ionisation mass spectrometry (LC-HR-ESI-MS) for dereplication purposes. Besides, the three major fractions (ethyl acetate, methanol, and n-butanol) obtained by chromatographic fractionation of the crude extract were evaluated for their anti-infective properties. RESULTS: A variety of metabolites, mostly peptides, were characterised herein for the first time from the genus Rhodococcus. Among the tested samples, the n-butanol fraction showed potent inhibitory activities against Staphylococcus aureus, Candida albicans, and Trypanosoma brucei brucei with IC50 values of 9.3, 6.7, and 8.7 μg/mL, respectively, whereas only the ethyl acetate fraction was active against Chlamydia trachomatis (IC50 = 18.9 μg/mL). In contrast, both fractions did not exert anti-infective actions against Enterococcus faecalis and Leishmania major, whereas the methanol fraction was totally inactive against all the tested organisms. CONCLUSION: This study showed the helpfulness of the established procedure in metabolic profiling of marine actinomycetes using liquid chromatography mass spectrometry (LC-MS) data, which aids in reducing the complex isolation steps during their chemical characterisation. The anti-infective spectrum of their metabolites is also interestingly relevant to future drug development.
INTRODUCTION: Marine sponge-associated actinomycetes are potent sources of bioactive natural products of pharmaceutical significance. They also contributed to the discovery of several clinically relevant antimicrobials. OBJECTIVE: To apply the non-targeted metabolomics approach in chemical profiling of the sponge-derived bacterium Rhodococcus sp. UA13, formerly recovered from the Red Sea sponge Callyspongia aff. Implexa, along with testing for the anti-infective potential of its different fractions. METHODOLOGY: Metabolomic analysis of the crude extract was carried out using liquid chromatography with high resolution electrospray ionisation mass spectrometry (LC-HR-ESI-MS) for dereplication purposes. Besides, the three major fractions (ethyl acetate, methanol, and n-butanol) obtained by chromatographic fractionation of the crude extract were evaluated for their anti-infective properties. RESULTS: A variety of metabolites, mostly peptides, were characterised herein for the first time from the genus Rhodococcus. Among the tested samples, the n-butanol fraction showed potent inhibitory activities against Staphylococcus aureus, Candida albicans, and Trypanosoma brucei brucei with IC50 values of 9.3, 6.7, and 8.7 μg/mL, respectively, whereas only the ethyl acetate fraction was active against Chlamydia trachomatis (IC50 = 18.9 μg/mL). In contrast, both fractions did not exert anti-infective actions against Enterococcus faecalis and Leishmania major, whereas the methanol fraction was totally inactive against all the tested organisms. CONCLUSION: This study showed the helpfulness of the established procedure in metabolic profiling of marine actinomycetes using liquid chromatography mass spectrometry (LC-MS) data, which aids in reducing the complex isolation steps during their chemical characterisation. The anti-infective spectrum of their metabolites is also interestingly relevant to future drug development.
Authors: Omnia Hesham Abdelhafez; John Refaat Fahim; Ramy R El Masri; M Alaraby Salem; Samar Yehia Desoukey; Safwat Ahmed; Mohamed Salah Kamel; Sheila Marie Pimentel-Elardo; Justin R Nodwell; Usama Ramadan Abdelmohsen Journal: RSC Adv Date: 2021-07-05 Impact factor: 4.036
Authors: Luca Ambrosino; Michael Tangherlini; Chiara Colantuono; Alfonso Esposito; Mara Sangiovanni; Marco Miralto; Clementina Sansone; Maria Luisa Chiusano Journal: Mar Drugs Date: 2019-10-11 Impact factor: 5.118
Authors: Momen M Lotfy; Ahmed M Sayed; Asmaa M AboulMagd; Hossam M Hassan; Dalia El Amir; Sameh F Abouzid; Ahmed O El-Gendy; Mostafa E Rateb; Usama R Abdelmohsen; Hani Alhadrami; Rabab Mohammed Journal: RSC Adv Date: 2021-02-09 Impact factor: 3.361
Authors: Enas Reda Abdelaleem; Mamdouh Nabil Samy; Taha F S Ali; Muhamad Mustafa; Mahmoud A A Ibrahim; Gerhard Bringmann; Safwat A Ahmed; Usama Ramadan Abdelmohsen; Samar Yehia Desoukey Journal: RSC Adv Date: 2022-01-21 Impact factor: 3.361
Authors: Reda F A Abdelhameed; Eman S Habib; Nermeen A Eltahawy; Hashim A Hassanean; Amany K Ibrahim; Anber F Mohammed; Shaimaa Fayez; Alaa M Hayallah; Koji Yamada; Fathy A Behery; Mohammad M Al-Sanea; Sami I Alzarea; Gerhard Bringmann; Safwat A Ahmed; Usama Ramadan Abdelmohsen Journal: Mar Drugs Date: 2020-05-03 Impact factor: 5.118
Authors: Reda F A Abdelhameed; Enas E Eltamany; Dina M Hal; Amany K Ibrahim; Asmaa M AboulMagd; Tarfah Al-Warhi; Khayrya A Youssif; Adel M Abd El-Kader; Hashim A Hassanean; Shaimaa Fayez; Gerhard Bringmann; Safwat A Ahmed; Usama Ramadan Abdelmohsen Journal: Mar Drugs Date: 2020-08-01 Impact factor: 5.118